Article
Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma.
PloS one - 1 Jan 2020
Chen Yu-Hung, Wang Tso-Fu, Chu Sung-Chao, Lin Chih-Bin, Wang Ling-Yi, Lue Kun-Han, Liu Shu-Hsin, Chan Sheng-Chieh
Abstract excerpt
BACKGROUND: To investigate the survival prognostic value of the radiomic features of 18F-FDG PET in patients who had EGFR (epidermal growth factor receptor) mutated lung adenocarcinoma and received targeted TKI (tyrosine kinase inhibitor) treatment. METHODS: Fifty-one patients with stage III-IV lung adenocarcinoma and actionable EGFR mutation who received first-line TKI were retrospectively analyzed. All patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
